Engineered autophagy receptors administered with extracellular vesicles eliminate pathological Tau and TDP-43
26 August 2026 at 08:00
Nature Biomedical Engineering, Published online: 26 August 2026; doi:10.1038/s41551-026-01774-9
Autophagy receptors are engineered fusing LC3 to cytoplasm-stable antibody variants and are delivered via small extracellular vesicles or adeno-associated virus to eliminate pathological Tau and TDP-43 in animal disease models.